PR Interval as a Novel Therapeutic Target of Ivabradine Therapy?Prognostic Impact of Ivabradine-Induced PR Prolongation in Heart Failure Patients

Yamamoto Riona; Kataoka Naoya; Imamura Teruhiko; Izumida Toshihide; Kinugawa Koichiro

doi:10.3390/jcm13020510

PR Interval as a Novel Therapeutic Target of Ivabradine Therapy?Prognostic Impact of Ivabradine-Induced PR Prolongation in Heart Failure Patients

Yamamoto Riona, Kataoka Naoya, Imamura Teruhiko, Izumida Toshihide, Kinugawa Koichiro

Research output: Contribution to journal › Article › peer-review

Original language	Japanese
Pages (from-to)	510-510
Journal	Journal of Clinical Medicine
Volume	13
Issue number	2
DOIs	https://doi.org/10.3390/jcm13020510
State	Published - 2024
Externally published	Yes

Access to Document

10.3390/jcm13020510

Cite this

@article{3f564512af6b4ca49e7c128acf1e7da4,

title = "PR Interval as a Novel Therapeutic Target of Ivabradine Therapy?Prognostic Impact of Ivabradine-Induced PR Prolongation in Heart Failure Patients",

author = "Yamamoto Riona and Kataoka Naoya and Imamura Teruhiko and Izumida Toshihide and Kinugawa Koichiro",

year = "2024",

doi = "10.3390/jcm13020510",

language = "日本",

volume = "13",

pages = "510--510",

journal = "Journal of Clinical Medicine",

number = "2",

}

TY - JOUR

T1 - PR Interval as a Novel Therapeutic Target of Ivabradine Therapy?Prognostic Impact of Ivabradine-Induced PR Prolongation in Heart Failure Patients

AU - Riona, Yamamoto

AU - Naoya, Kataoka

AU - Teruhiko, Imamura

AU - Toshihide, Izumida

AU - Koichiro, Kinugawa

PY - 2024

Y1 - 2024

U2 - 10.3390/jcm13020510

DO - 10.3390/jcm13020510

M3 - 学術論文

VL - 13

SP - 510

EP - 510

JO - Journal of Clinical Medicine

JF - Journal of Clinical Medicine

IS - 2

ER -